DOP2002000449A - Sal sodica de un inhibidor de integradasa del vih. - Google Patents

Sal sodica de un inhibidor de integradasa del vih.

Info

Publication number
DOP2002000449A
DOP2002000449A DO2002000449A DO2002000449A DOP2002000449A DO P2002000449 A DOP2002000449 A DO P2002000449A DO 2002000449 A DO2002000449 A DO 2002000449A DO 2002000449 A DO2002000449 A DO 2002000449A DO P2002000449 A DOP2002000449 A DO P2002000449A
Authority
DO
Dominican Republic
Prior art keywords
sodium salt
hiv
inhibitor
integradasa
compound
Prior art date
Application number
DO2002000449A
Other languages
English (en)
Inventor
Wei Xu
Neville J Anthony
John V Lepore
Amar J Mahajan
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DOP2002000449A publication Critical patent/DOP2002000449A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se divulga una sal de sodio del compuesto A, donde el compuesto A tiene la fórmula: Compuesto A E1 compuesto A es un iúhibidor de la integrasa del VIH, que es útil para prevenir o tratar la infección por el VIH, para demorar el inicio del SIDA y para el tratamiento del SIDA.
DO2002000449A 2001-08-17 2002-08-15 Sal sodica de un inhibidor de integradasa del vih. DOP2002000449A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31337301P 2001-08-17 2001-08-17

Publications (1)

Publication Number Publication Date
DOP2002000449A true DOP2002000449A (es) 2003-05-15

Family

ID=23215462

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2002000449A DOP2002000449A (es) 2001-08-17 2002-08-15 Sal sodica de un inhibidor de integradasa del vih.

Country Status (7)

Country Link
US (1) US6924282B2 (es)
EP (1) EP1430058A1 (es)
JP (1) JP2005501857A (es)
AR (1) AR036256A1 (es)
CA (1) CA2456206A1 (es)
DO (1) DOP2002000449A (es)
WO (1) WO2003016315A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002030931A2 (en) * 2000-10-12 2002-04-18 Merck & Co., Inc. Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
WO2003077857A2 (en) * 2002-03-15 2003-09-25 Merck & Co., Inc. N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
AU2004259675A1 (en) * 2003-07-15 2005-02-03 Merck & Co., Inc. Hydroxypyridine CGRP receptor antagonists
ATE433974T1 (de) 2003-09-19 2009-07-15 Gilead Sciences Inc Azachinolinolphosphonatverbindungen als integraseinhibitoren
PL1742642T3 (pl) * 2004-04-14 2009-06-30 Gilead Sciences Inc Analogi fosfonianowe związków inhibitorów integrazy HIV
EA016267B1 (ru) 2006-09-29 2012-03-30 Айденикс Фармасьютикалз, Инк. Энантиомерно чистые фосфоиндолы в качестве ингибиторов hiv

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2632639B1 (fr) * 1988-06-09 1990-10-05 Sanofi Sa Derives d'amino-4 carboxy-3 naphtyridines, leur preparation et compositions pharmaceutiques qui les contiennent
IL101860A0 (en) * 1991-05-31 1992-12-30 Ici Plc Heterocyclic derivatives
US5681832A (en) 1995-02-17 1997-10-28 The United States Of America As Represented By The Department Of Health And Human Services Aroylaniline compounds, pharmaceutical compositions, and methods of using same to inhibit viral activity
US5945431A (en) * 1996-03-15 1999-08-31 Biochem Therapeutics Incorporated Cytomegalovirus inhibiting compounds
AU4172197A (en) * 1996-09-10 1998-04-02 Pharmacia & Upjohn Company 8-hydroxy-7-substituted quinolines as anti-viral agents
WO1998013350A1 (en) 1996-09-25 1998-04-02 Zeneca Limited Qinoline derivatives inhibiting the effect of growth factors such as vegf
CA2295309A1 (en) * 1997-06-30 1999-01-07 Nippon Kayaku Kabushiki Kaisha Novel naphthyridine derivatives or salts thereof
EP1007526A1 (en) 1997-08-25 2000-06-14 Neurogen Corporation Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands
NZ505362A (en) 1997-12-22 2004-12-24 Upjohn Co 4-hydroxyquinoline-3-carboxamides and -hydrazides useful as antiviral agents
US6306891B1 (en) * 1998-06-03 2001-10-23 Merck & Co., Inc. HIV integrase inhibitors
US6380249B1 (en) * 1998-06-03 2002-04-30 Merck & Co., Inc. HIV integrase inhibitors
US6262055B1 (en) * 1998-06-03 2001-07-17 Merck & Co., Inc. HIV integrase inhibitors
AU5880600A (en) 1999-06-25 2001-01-31 Merck & Co., Inc. 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
US6730682B2 (en) 2000-07-12 2004-05-04 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
GB0017676D0 (en) 2000-07-19 2000-09-06 Angeletti P Ist Richerche Bio Inhibitors of viral polymerase
WO2002030931A2 (en) * 2000-10-12 2002-04-18 Merck & Co., Inc. Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
ATE355064T1 (de) 2001-10-26 2006-03-15 Angeletti P Ist Richerche Bio Dihydroxypyrimidin-carbonsäueramid-hemmer der hiv-integrase
HU230248B1 (hu) 2001-10-26 2015-11-30 Msd Italia S.R.L. N-szubsztituált hidroxipirimidinon-karboxamid HIV-integráz inhibitorok

Also Published As

Publication number Publication date
US20030119823A1 (en) 2003-06-26
EP1430058A1 (en) 2004-06-23
JP2005501857A (ja) 2005-01-20
CA2456206A1 (en) 2003-02-27
WO2003016315A1 (en) 2003-02-27
AR036256A1 (es) 2004-08-25
US6924282B2 (en) 2005-08-02

Similar Documents

Publication Publication Date Title
TNSN07215A1 (en) Potassium salt of an hiv integrase inhibitor
EA200400022A1 (ru) Соединения и способы лечения или предупреждения инфекций flavivirus
LV12719A (lv) Benzoxazinones as inhibitors of hiv reverse transcriptase
BR0316771A (pt) Compostos para o tratamento ou a prevenção de infecções por flavivirus, uso de um composto e composição farmacêutica
BR0309581A (pt) Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
NO305478B1 (no) Hydroksyetylaminosulfonamider som retrovirale proteasehemmere
MX9403380A (es) Inhibidores de proteasa de vih utiles para el tratamiento de sida.
ES2125251T3 (es) Inhibidores de la proteasa del vih.
DK0749421T3 (da) Sulfonamidderivater som aspartylproteaseinhibitorer
DE60036961D1 (de) Gamma-hydroxy-2-(fluoralkylaminocarbonyl)-1-piperazinpentanamide als hiv-proteasehemmer
UY26380A1 (es) Inhibidores de fab i
CY1106801T1 (el) Νεες ετεροκυκλικες ενωσεις, η παρασκευη τους και η χρηση τους ως φαρμακα, ιδιαιτερα ως αντιβακτηριακα
SE0102315D0 (sv) Compounds
ES2051641B1 (es) Procedimientos para la preparacion de compuestos derivados de tiourea.
NO20063958L (no) HIV integrase inhibitorer
GEP20207190B (en) Methods for treatment and prophylaxis of hiv and aids
ES2174921T3 (es) Inhibidores de la proteasa del vih.
GEP20257744B (en) Antimalarial agents
AR029544A1 (es) Composiciones y metodos para tratar infecciones bacterianas
DOP2002000449A (es) Sal sodica de un inhibidor de integradasa del vih.
CO4130200A1 (es) Inhibidores de proteasa del hiv utiles en el tratamiento del sida
MX2022004912A (es) Novedoso compuesto de anillo condensado sustituido.
TW200738700A (en) HIV integrase inhibitors
PT1140113E (pt) Utilizacao de bisfosfonatos para profilaxia e tratamento de processos infecciosos
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.